| scholarly article | Q13442814 |
| editorial | Q871232 |
| P6179 | Dimensions Publication ID | 1034453311 |
| P356 | DOI | 10.1007/S00395-009-0080-9 |
| P698 | PubMed publication ID | 20066536 |
| P50 | author | Rainer Schulz | Q47430697 |
| P2093 | author name string | Kerstin Boengler | |
| Gerd Heusch | |||
| P433 | issue | 2 | |
| P304 | page(s) | 151-154 | |
| P577 | publication date | 2010-03-01 | |
| P1433 | published in | Basic Research in Cardiology | Q2453360 |
| P1476 | title | Inhibition of mitochondrial permeability transition pore opening: the Holy Grail of cardioprotection | |
| P478 | volume | 105 |
| Q26852055 | Q26852055 |
| Q36011190 | A novel role for mitochondrial sphingosine-1-phosphate produced by sphingosine kinase-2 in PTP-mediated cell survival during cardioprotection. |
| Q38276607 | Absence of type VI collagen paradoxically improves cardiac function, structure, and remodeling after myocardial infarction |
| Q34044380 | Active Wnt signaling in response to cardiac injury |
| Q35989587 | Adora2b signaling on bone marrow derived cells dampens myocardial ischemia-reperfusion injury |
| Q54382040 | Akt and Erk1/2 activate the ornithine decarboxylase/polyamine system in cardioprotective ischemic preconditioning in rats: the role of mitochondrial permeability transition pores. |
| Q48128764 | Angiotensin (1-7) facilitates cardioprotection of ischemic preconditioning on ischemia-reperfusion-challenged rat heart. |
| Q34247492 | BNP controls early load-dependent regulation of SERCA through calcineurin |
| Q35944872 | Blockade of electron transport at the onset of reperfusion decreases cardiac injury in aged hearts by protecting the inner mitochondrial membrane |
| Q38018510 | Calcium antagonists in myocardial ischemia/reperfusion--update 2012. |
| Q50782343 | Cardiac protective effects of remote ischaemic preconditioning in children undergoing tetralogy of fallot repair surgery: a randomized controlled trial. |
| Q37160528 | Cardiac vulnerability to ischemia/reperfusion injury drastically increases in late pregnancy |
| Q42318959 | Cardiomyocyte mitochondria as targets of humoral factors released by remote ischemic preconditioning |
| Q38199493 | Cardioprotection and pharmacological therapies in acute myocardial infarction: Challenges in the current era. |
| Q36802290 | Cardioprotection by mild hypothermia during ischemia involves preservation of ERK activity |
| Q39205719 | Cardioprotection with halogenated gases: how does it occur? |
| Q38055280 | Cardioprotection: chances and challenges of its translation to the clinic |
| Q36183707 | Cardioprotective effect of berberine against myocardial ischemia/reperfusion injury via attenuating mitochondrial dysfunction and apoptosis |
| Q34061092 | Cellular and molecular pathways to myocardial necrosis and replacement fibrosis |
| Q35995871 | Clinical applications of remote ischaemic preconditioning in native and transplant acute kidney injury |
| Q41561212 | Clinical applications of remote ischemic preconditioning |
| Q33712409 | Clinically-relevant consecutive treatment with isoproterenol and adenosine protects the failing heart against ischaemia and reperfusion |
| Q36073461 | Comparison Review of Short-Acting and Long-Acting Glucagon-like Peptide-1 Receptor Agonists |
| Q33791098 | Cyclosporine A at reperfusion reduces infarct size in pigs |
| Q91740190 | Different adaptive NO-dependent Mechanisms in Normal and Hypertensive Conditions |
| Q36078415 | Differential Tissue-Specific Function of Adora2b in Cardioprotection |
| Q41892420 | Disrupting the EMMPRIN (CD147)-cyclophilin A interaction reduces infarct size and preserves systolic function after myocardial ischemia and reperfusion |
| Q41755944 | Distinct cardioprotective mechanisms of immediate, early and delayed ischaemic postconditioning |
| Q61448991 | Ebselen protects rat hearts against myocardial ischemia-reperfusion injury |
| Q38479165 | Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA): rationale and study design of a multi-centre randomized double-blinded controlled clinical trial. |
| Q36078945 | Emerging beneficial roles of sirtuins in heart failure. |
| Q35928926 | Endothelial-cardiomyocyte crosstalk enhances pharmacological cardioprotection |
| Q42861824 | Ethanolamine is a novel STAT-3 dependent cardioprotective agent |
| Q30423231 | Evidence for an intracellular localization of the adenosine A2B receptor in rat cardiomyocytes |
| Q35286339 | Extracellular signalling molecules in the ischaemic/reperfused heart - druggable and translatable for cardioprotection? |
| Q39023204 | Global cerebral ischemia due to circulatory arrest: insights into cellular pathophysiology and diagnostic modalities |
| Q46359823 | High-Density Lipoprotein Regulation of Mitochondrial Function |
| Q38827052 | High-density lipoprotein, mitochondrial dysfunction and cell survival mechanisms |
| Q92581881 | Hydroxysafflor Yellow A mitigated myocardial ischemia/reperfusion injury by inhibiting the activation of the JAK2/STAT1 pathway |
| Q36159289 | Increase in Cardiac Ischemia-Reperfusion Injuries in Opa1+/- Mouse Model. |
| Q41892475 | Infarct size reduction by cyclosporine A at reperfusion involves inhibition of the mitochondrial permeability transition pore but does not improve mitochondrial respiration |
| Q34300508 | Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion |
| Q37160450 | Intralipid, a clinically safe compound, protects the heart against ischemia-reperfusion injury more efficiently than cyclosporine-A. |
| Q47135870 | Intramyocardial injection of thioredoxin 2-expressing lentivirus alleviates myocardial ischemia-reperfusion injury in rats |
| Q28072918 | Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery |
| Q38683468 | Ischemia reperfusion injury, ischemic conditioning and diabetes mellitus |
| Q37668843 | Ischemia/Reperfusion Injury following Acute Myocardial Infarction: A Critical Issue for Clinicians and Forensic Pathologists |
| Q35113412 | Ischemia/reperfusion injury and cardioprotective mechanisms: Role of mitochondria and reactive oxygen species |
| Q35056941 | Ischemic preconditioning attenuates mitochondrial localization of PTEN induced by ischemia-reperfusion |
| Q37670940 | Liraglutide directly protects cardiomyocytes against reperfusion injury possibly via modulation of intracellular calcium homeostasis. |
| Q34636288 | Long-term impact of postconditioning on infarct size and left ventricular ejection fraction in patients with ST-elevation myocardial infarction |
| Q34973798 | Loss of interstitial collagen causes structural and functional alterations of cardiomyocyte subsarcolemmal mitochondria in acute volume overload |
| Q35783843 | Mechanical post-conditioning in STEMI patients undergoing primary percutaneous coronary intervention |
| Q36720566 | Methods for assessing mitochondrial function in diabetes |
| Q35492308 | Mitochondria to nucleus translocation of AIF in mice lacking Hsp70 during ischemia/reperfusion |
| Q41985174 | Mitochondria-targeted Cardioprotection in Aldosteronism |
| Q37686149 | Mitochondrial targeted peptides attenuate residual myocardial damage after reversal of experimental renovascular hypertension |
| Q35799662 | Mitochondrial-dependent Autoimmunity in Membranous Nephropathy of IgG4-related Disease |
| Q37052474 | Molecular basis of cardioprotective effect of antioxidant vitamins in myocardial infarction |
| Q48221861 | Molecular imaging of cardiac remodelling after myocardial infarction |
| Q26784080 | Myocardial Dysfunction and Shock after Cardiac Arrest |
| Q97069866 | Myocardial ischaemia-reperfusion injury and cardioprotection in perspective |
| Q36278316 | Myocardial ischemia reperfusion injury: from basic science to clinical bedside |
| Q36497176 | Myocardial ischemia-reperfusion injury: a neglected therapeutic target. |
| Q40602084 | Nanoparticle-Mediated Delivery of Mitochondrial Division Inhibitor 1 to the Myocardium Protects the Heart From Ischemia-Reperfusion Injury Through Inhibition of Mitochondria Outer Membrane Permeabilization: A New Therapeutic Modality for Acute Myoca |
| Q37007953 | New horizons in cardioprotection: recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop |
| Q37776431 | New insights into the role of thyroid hormone in cardiac remodeling: time to reconsider? |
| Q38759797 | Nitrite-Nitric Oxide Signaling and Cardioprotection |
| Q34970177 | Nogo-A knockdown inhibits hypoxia/reoxygenation-induced activation of mitochondrial-dependent apoptosis in cardiomyocytes. |
| Q38177382 | Optimising cardioprotection during myocardial ischaemia: targeting potential intracellular pathways with glucagon-like peptide-1 |
| Q35556989 | Pharmacological postconditioning with lactic acid and hydrogen rich saline alleviates myocardial reperfusion injury in rats |
| Q91860378 | Pharmacology of mitochondrial permeability transition pore inhibitors |
| Q84040560 | Post-ischemic early acidosis in cardiac postconditioning modifies the activity of antioxidant enzymes, reduces nitration, and favors protein S-nitrosylation |
| Q54520877 | Protective effect of ischemic postconditioning against ischemia reperfusion-induced myocardium oxidative injury in IR rats. |
| Q51170295 | RETRACTED: Compensatory role of the NBCn1 sodium/bicarbonate cotransporter on Ca2+-induced mitochondrial swelling in hypertrophic hearts. |
| Q35286322 | Redox signalling and cardioprotection: translatability and mechanism |
| Q33919143 | Reduction of early reperfusion injury with the mitochondria-targeting peptide bendavia |
| Q54977065 | Remote Ischemic Conditioning in Cerebral Diseases and Neurointerventional Procedures: Recent Research Progress. |
| Q41532167 | Remote postconditioning by humoral factors in effluent from ischemic preconditioned rat hearts is mediated via PI3K/Akt-dependent cell-survival signaling at reperfusion |
| Q36895471 | Roles of STATs signaling in cardiovascular diseases |
| Q61801386 | Snapshot: Implications for mTOR in Aging-related Ischemia/Reperfusion Injury |
| Q26825240 | Stenting technique, gender, and age are associated with cardioprotection by ischaemic postconditioning in primary coronary intervention: a systematic review of 10 randomized trials |
| Q54639525 | Survivin signalling in the heart |
| Q37767172 | TNFα in myocardial ischemia/reperfusion, remodeling and heart failure |
| Q36148170 | TNFα protects cardiac mitochondria independently of its cell surface receptors |
| Q99615238 | The Rationale of Neprilysin Inhibition in Prevention of Myocardial Ischemia-Reperfusion Injury during ST-Elevation Myocardial Infarction |
| Q47255415 | The antiarrhythmic dipeptide ZP1609 (danegaptide) when given at reperfusion reduces myocardial infarct size in pigs |
| Q49238182 | The effects of remote ischaemic preconditioning on coronary artery function in patients with stable coronary artery disease |
| Q37850517 | The in-situ pig heart with regional ischemia/reperfusion - ready for translation. |
| Q92711721 | Traditional Chinese Medicine for Coronary Heart Disease: Clinical Evidence and Possible Mechanisms |
| Q34247485 | Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations |
| Q92847557 | Translational issues for mitoprotective agents as adjunct to reperfusion therapy in patients with ST-segment elevation myocardial infarction |
| Q38542449 | Treatment of Myocardial Ischemia/Reperfusion Injury by Ischemic and Pharmacological Postconditioning |
| Q35060592 | mtDNA T8993G mutation-induced F1F0-ATP synthase defect augments mitochondrial dysfunction associated with hypoxia/reoxygenation: the protective role of melatonin |
Search more.